Sertoli-Leydig cell tumor (SLCT) of the ovary is an exceedingly unusual neoplasm that belongs to a group of sex cord-stromal tumors of the ovary and accounts for less than 0.5% of all primary ovarian neoplasms. We present a case of primary ovarian SLCT in a 21-year-old female who presented with a 6-month history of pelvic pain, acne, hirsuitism and oligomenorrhea with elevated testosterone and dehydroepiandrosterone levels. Ultrasound and contrast computed tomography revealed a well-defined hypervascular heterogeneous solid lesion in the left adnexa. Magnetic resonance imaging demonstrated an ovarian origin of the tumor, which indicated an SLCT on histopathology. In this case, we discuss the multimodality imaging findings of SLCT and its management aspects with a review of the literature. Gupta, et al.: Androblastoma 
INTRODUCTION
Sertoli-Leydig cell tumor (SLCT) is a rare ovarian tumor that belongs to the group of sex-cord stromal tumors. These constitute less than 0.5% of ovarian tumors. [1] Most tumors are unilateral and confined to the ovaries, and are seen during the second and third decades of life. These tumors are characterized by the presence of testicular structures that produce androgens. Hence, many patients have symptoms of virilization depending on the quantity of androgen production. We present a case of SLCT with multimodality imaging findings and its management issues.
CASE REPORT
A 21-year-old nulliparous female presented with complaints of pelvic pain, acne, hirsuitism, hoarseness of voice and oligomenorrhea for the last 6 months. No history of anorexia, weight loss, increased libido or breast recession was noted. Her medical and family history was unremarkable. Vaginal examination revealed clitoromegaly and a firm and mobile solid mass in the left adnexa. Laboratory tests showed elevated serum testosterone of 27.6 ng/mL (normal range 0.2-1.2 ng/mL) and dehydroepiandrosterone of 16.3 ng/mL (normal range 0.8-3.2 ng/mL) and normal CA-125 of 22 U/mL (normal range <35 U/mL). All other laboratory tests including complete blood count (CBC), renal, bone, hepatic and coagulation profiles, alkaline phosphatase, carcino-embryonic antigen (CEA), luteinizing hormone (LH) and follicle stimulating hormone (FSH) levels were within the normal range.
Further, the patient was referred for imaging workup to our department. Ultrasound showed a large, well-circumscribed, well-marginated heterogeneous mixed solid-cystic lesion [ Figure 1a ] in the left adnexa with internal vascularity on color Doppler [ Figure 1b ]. The right ovary and the uterus were normal [ Figure 1c ].
Subsequently, cross-sectional imaging was performed; unenhanced computed tomography (CT) demonstrated a large, well-circumscribed solid lesion on the left side of the pelvic cavity [ Figure 2a ]. On contrast-enhanced computed tomography (CECT), the lesion showed heterogenous enhancement more in the peripheral part (corresponds to the solid part of the lesion on ultrasound) and less in the enhancing central part (corresponds to the cystic part of the lesion on ultrasound). The left ovary is not distinctly visualized from the lesion. Blood supply to the lesion was coming from a vascular pedicle on its anterior aspect [ Figure 2b ]. The lesion causes displacement of the uterus inferiorly and toward the right side. The right adnexa appeared unremarkable [ Figure 3a ]. No evidence of paraaortic lymphadenopathy was noted [ Figure 3b ].
Nonenhanced magnetic resonance imaging (MRI) of the pelvis -T2-weighted images showed heterogeneous signal intensity lesion with few central cystic areas in the left adnexa. The lesion causes compression and peripheral displacement of the follicles, suggestive of ovarian origin [ Figure 4 ]. The lesion showed multiple signal voids. The uterus and right ovary appeared unremarkable [ Figure 5a ]. The T1-weighted image demonstrated isointense signal and multiple signal voids [ Figure 5b ]. On the basis of the above clinical, biochemical and imaging findings, a diagnosis of androgenic neoplastic primary ovarian tumor was made.
The patient underwent exploratory laparotomy. Intraoperatively, the left ovary was replaced by a large capsulated solid greywhite mass [ Figure 6a ]. The right ovary and uterus were found unremarkable. Left salpingo-oophorectomy was performed. Gross examination of the pathologic specimen [ Figure 6b ] showed an ovarian mass with a smooth external grayish surface. A cut-section of the specimen [ Figure 6c ] revealed solid as well as cystic areas filled with clear fluid. The histopathological examination showed a tumor composed of poorly formed cords, nests and tubules of tumor cells. Tumor cells had hyperchromatic nuclei, a moderate amount of cytoplasm (Sertoli cells) and occasional mitosis [ Figure 6d ]. Interspersed between these were nests of polygonal cells with round nuclei and abundant granular cytoplasm (Leydig cells). Final diagnosis was intermediately differentiated SLCT on histopathology.
DISCUSSION
SLCT is a very rare ovarian tumor that is included in the group of sex-cord stromal tumors, and they account for less than 0.5% of all primary ovarian tumors. [1] It is usually seen in the reproductive age group (second and third decades of life). [1] [2] [3] [4] [5] Clinical presentation is related to either hormonal production (mostly androgen and rarely estrogen) [6] or presence of mass-occupying lesion. [1] [2] [3] Androgen-excess manifestations include virilism, hirsuitism, hoarseness of voice, clitoromegaly, oligomenorrhea and amenorrhea. [7, 8] Imaging studies can be used in the diagnosis of ovarian SLCTs. Sonography remains the best imaging modality of preference for the initial assessment of adnexal masses due to its high sensitivity, suitability and cost-effectiveness. [6, 9] SLCTs typically exhibit solid sonographic appearance [6, 9] and mostly unilateral tumors. [1] [2] [3] 5] Mixed (solid and cystic) components are most commonly encountered in roughly 60% of all ovarian SLCTs. [1] Color Doppler sonography offers further categorization and evaluation of neoplastic masses. Moderate-to-rich ovarian vascular masses with low-resistance indices highly suggest malignant rather than benign lesions. Other imaging modalities such as CT, MRI and positron imaging tomography (PET) scans can be used for better characterization of ovarian SLCTs and detection of extraovarian disease/metastasis. SLCTs appear as hypervascular mixed solid-cystic lesions within the adnexa on CT or MRI. Cross-sectional imaging can be used for staging of the tumor preoperatively.
Macroscopically, [10] SLCTs are well-encapsulated, solid, firm and yellow-gray masses. The cut-section surface exhibits varying degrees of greasy/fleshy consistency, straw-colored fluid, necrosis, hemorrhage and cystic spaces separated by fibrous septae. Microscopically, [10] SLCTs are made up of uncontrolled proliferation of differentiation of tubules lined by Sertoli cells and intervening nests of Leydig cells. Leydig cells are typically found in clusters in the interstitial stroma and exhibit polygonal cells with well-defined margins, centric nuclei, prominent nucleoli and eosinophilic cytoplasm. Sertoli cells typically form tubular structures lined by single or multiple layers of cuboidal-columnar cells with well-bounded margins, oval dark nuclei, inconspicuous nucleoli and eosinophilic or vacuolated cytoplasm.
Surgical resection represents the mainstay of management of ovarian SLCTs. [4] Therefore, fertility-sparing surgery (unilateral salpingo-oophorectomy) can be considered in all patients with well-differentiated ovarian SLCTs. Generally, postoperative chemotherapy is considered for patients with poor prognostic factors such as advanced disease staging, moderate-to-poor tumor grading, high mitotic profile, existence of heterologous elements and tumor rupture. [1] [2] [3] Prognosis of ovarian SLCTs is significantly correlated with degree of tumor differentiation (grading) and tumor extent (staging). [1] Long-term follow-up is highly advised in all patients.
CONCLUSION
SLCT is a rare ovarian sex-cord tumor of the ovary with good prognosis postoperatively. Therefore, imaging findings may help in the early detection and preoperative differentiation and staging of SLCT in young females. Its management depends on the degree of differentiation and staging of tumor, which mostly depend on histopathology. Intermediately differentiated tumors require additional management of chemotherapy along with conservative surgery to prevent recurrence.
